Home
|
Learning Center
|
中文版
Publications
Search Publications:
search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
other
Abstract 632: Tumor-targe......Abstract A74: Differentia
Abstract A63: Time course......Abstract B15: Motivation
Abstract B47: Association......Abstract PL05-01: Obesity
Abstract CN05-02: Exploit......Abstract B13: Knowledge,
Abstract A36: Recreationa......Abstract LB-050: Patient-
Abstract 545: Plasma-base......Abstract 394: A novel ant
Abstract 1940: Dual inhib......Abstract 4638: Fine mappi
Abstract 2454: Targeting ......Abstract 2322: The Hippo
Abstract 3879: Patient pr......Abstract 4725: Hematopoie
Abstract 5139: Cell sorti......Abstract LB-130: Reporter
Abstract 5306: Microparti......Abstract 4858: Cloud-base
Abstract LB-111: Comprehe......Abstract 5366: Propentofy
Abstract 5357: Inhibition......Abstract IA19: The evolut
Abstract IA25: Targeting ......Abstract 1948: Human papi
Abstract 2954: A noncanon......Abstract 4609: MEF2 plays
Abstract 1079: COX-2 bloc......Abstract 3485: Efficient
Abstract CT406: Aerosol i......Abstract 2349: An RNA-bas
Abstract 4903: Luteolin's......Abstract 3382: Nifurtimox
Abstract 4934: Imaging an......Abstract 1518: A new mult
Abstract 4087: Identifica......Abstract 1148: Epithelial
Abstract 113: A comparati......Abstract 2152: Akt/surviv
Abstract 4649: Using phar......Abstract LB-229: A phase
Abstract 2295: Epigenetic......Abstract 3115: Calcitriol
Abstract 1224: A patient ......Abstract LB-106: Microtub
Abstract 4711: The PI3K-δ......Abstract 3702: Integrated
Abstract 3720: Intrinsic ......Abstract 3816: Correlatio
Abstract 3833: Molecular ......Abstract 4720: Evaluation
Abstract LB-293: Circulat......Abstract 4775: PI3K-p110β
Abstract 240: Natural ant......Abstract 5401: Investigat
Abstract 3442: Non-canoni......Abstract 346: Differentia
Abstract 2323:Interferon ......Abstracts of the Fourth A
Abstracts of Keynote Sess......Abstract P16
Abstract P8......Abstract 5598: Correlatin
Abstract 2713: Small-mole......Abstract 4091: Interferin
Abstract 263: African Ame......Abstract 7: Assessment of
Abstract 2726: RET fusion......Abstract 2707:In vitroand
Abstract 19: PlGF/VEGFR-1......Abstract 14: Identificati
Abstract IA18: Molecular ......Abstracts of the Chinese
Abstracts of the English ......Abstract 3506: Heregulin
Abstract 351: Comparative......Abstract 2841: Characteri
Abstract 2836: Developmen......Abstract 4457: Regulation
Abstract 2885: Therapeuti......Abstract 4411: DRAK1 over
Abstract 978: microRNA-21......Abstract A52: In vivo mod
Abstract A2: Using plexif......Abstract IA17: Targeting
Abstracts and Case Studie......Abstract number 17: Robot
Abstract number 12: Predi......Abstract B77: Shared deci
Abstract B78: Assessing b......Abstract P45
Abstract 21......Abstract 12
Abstract 88......Abstract 16
Abstract 128......Abstract 664: Amanitin-ba
Abstracts (French, Spanis......Abstracts
Abstract B118: An efficie......Abstract withdrawn
Abstracts......Abstract PR05: Reversing
Abstract A34: Nucleosome ......Abstracts en este numero
Abstracts......Abstract 23
Abstract 16......Abstract 169
Abstract 168......Abstract 201
Abstract 203......Abstract 637: Antisense t
Abstract 63: Incorporatio......Abstract 3371: Preclinica
Abstract 3386: Mechanisms......Abstract 4194: The heredi
Abstract 3253: A novel sm......Abstract 1816: SULT1A1 ge
Abstract 66: Pharmacologi......Abstract 2280: Targeted m
Abstract 1801: ERK-mediat......Abstract 5383: Overexpres
Abstract 1111: Whole geno......Abstract 2985: The histon
Abstract 917: High antitu......Abstract 3005: Cdca7l is
Abstract 3003: Aurora kin......Abstract 5626: EBP50: Nov
Abstract 924: FAK inhibit......Abstract 1054: Targeting
Abstract 5540: Crosstalk ......Abstract 5558: Lurbinecte
Abstract 5209: Characteri......Abstract 556: Cot/Tpl2 is
Abstract 5560: Characteri......Abstract 1841: Characteri
Abstract 5220: Identifyin......Abstract 3210: Proteomic
Abstract 5584: Finding pr......Abstract 1951: miRNA expr
Abstract 5323: Innovative......Abstract 2553: Characteri
Abstract 1865: Ciglitazon......Abstract 2035: Anti-epile
Abstract 4092: Identifyin......Abstract 2018: Genome-wid
Abstract 2019: Whole exom......Abstracts
Abstracts of the Rehabili......Abstract 831: Elucidating
Abstract 832: MicroRNA-30......Abstract LB-354: Pediatri
Abstract 2296: Sequencing......Abstract 4939: MicroRNA-3
Abstract 3897: A novel fu......Abstract LB-193: Phase I
Abstract 1149: Prognostic......Abstract 4209: Genotypic
Abstract 4207: The germli......Abstract 1775: High resol
Abstract 1773: Nucleotide......Abstract 1793: ADAR1 regu
Abstract 1280: Pterostilb......Abstract 5484: Heterogene
Abstract 5489: CRK protei......Abstract 2880: A prospect
Abstract 4380: Splicing f......Abstract LB-217: A gene s
Abstract 2810: Evaluating......Abstract 4436: The down-r
Abstract 4437: Regulation......Abstract 3940: Ezrin is a
Abstract 267: MYC maintai......Abstract 4497: TW01001, a
Abstract 4496: Differenti......Abstract 4471: Combined b
Abstract 2166: Rapamycin ......Abstract 1347: CXCR4 path
Abstract 4243: Regulation......Abstract 2175: Src homolo
Abstract 2860: A critical......Abstract 440: The subleth
Abstract 3469: The expres......Abstracts from the Intern
Abstracts......Abstract A32: Colorectal
Abstract A34: Microenviro......Abulia Due to Injury of t
阿布拉姆·盖姆斯......Abundance and Diversity o
Abundance and diversity o......Abundance and use of cavi
Abundances of Sulfur, Sel......Abundance of specific mRN
Abundance and Relative Di......Abundance of Panamanian d
Abundances of Jupiter's t......Abundance, characteristic
Abundance analysis of the......Abundance, distribution,
Abundance profiles and co......Abundance of Pathogenic E
Abundance and diversity o......Abundance and size struct
